Archiv der Pharmazie p. 233 - 234 (1997)
Update date:2022-08-05
Topics: Synthesis NMR spectroscopy Mass spectrometry Reaction Conditions In vitro assay Bone resorption
Pifferi, Giorgio
Da Re, Paolo
Valenti, Piero
Bisi, Alessandra
Malandrino, Salvatore
A topological modification of ipriflavone 1, a recent antiosteoporotic drug, is described, The flavone moiety of 1 has been replaced by a xanthone one, Among the new derivatives, the 3,6-diisopropoxyxanthone (2a) has shown significant bone resorption inhibition in in vitro and in vivo tests.
View Morewebsite:http://www.coreychem.com
Contact:+86-371-86658258
Address:Building 10 of Innovation Park, East District of the National University Science Park
Suqian Ruixing Chemical Co., Ltd.
Contact:+86-527-80805666（总机）;84836008(销售)
Address:3 Jingsilu, Zone north, Hubin Xincheng Development Park, Suqian, China
Anqing World Chemical Co., Ltd.
Contact:+86-556-5800026
Address:Daguan Economic Development Zone of circular economy industrial park Anqing City Anhui province
Shanghai Science Peptide Biological Technology Co.,ltd
website:http://www.scipeptide.com
Contact:+86-21-51099675
Address:No.8 Changyang Rd
HENAN NEW BLUE CHEMICAL CO.,LTD
website:http://www.newbluechem.com
Contact:86-371-55170693/55170694
Address:Zhengzhou International Trade New Territory,Jinshui District,Zhengzhou ,China
Doi:10.1002/jps.2600650319
(1976)Doi:10.1021/ja00422a036
(1976)Doi:10.1021/ja01566a077
(1957)Doi:10.1139/v00-113
(2000)Doi:10.1021/jo034447c
(2003)Doi:10.1021/jacs.1c05852
(2021)
